Skip to main content
. 2012 May 9;75(1):93–102. doi: 10.1111/j.1365-2125.2012.04319.x

Table 1.

Demographics at screen

Screen number Age(years)/Gender BDP (µg ) LABA (L), Nasal steroid (N), LAMA(T), Antihistamine (A) FEV1 (%) Residual volume (%) Resistance at 5 Hz (R5%) Mannitol PD10
1 50/M 1600 L 77 159 202 95.53
2 52/F 2000 L 66 456 115 30.39
6 52/M 1000 LNA 67 83 109 139.73
3 63/M 1600 LN 54 142 215 170.37
10 37 M 2000 LA 71 170 129 13.28
23 65F 1000 L 49 216 192 337.32
27 48 M 2000 L 67 130 130 192.50
31 40/M 2000 LA 44 224 213 NR
32 28/M 1000 L 64 140 214 96.94
36 43 M 2000 L 70 162 286 455.89
37 65/M 1600 69 147 151 129.27
38 60/M 2000 57 128 153 443.57
39 61/F 2000 N 48 185 142 NR
40 52/M 2000 L 63 153 200 121.69
41 52/M 2000 LN 38 188 306 NR
Mean (SD) 51 (10) 1635 (448) 58 (13) 193 (100) 184 (56) 177 (2.81)

Challenge not performed as FEV1 < 50% predicted. BDP, beclomethasone diproprionate equivalent; LABA, long acting beta-agonist; LAMA, long acting anti-muscarinic.